Articles published by Love Pharma Inc.
Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Address Unmet Medical Need—Treatment for Long Covid
November 03, 2022
From Love Pharma Inc.
Via GlobeNewswire
Tickers
CSE:LUV
Love Pharma Inc. Announces Second Closing of Financing
June 29, 2022
From Love Pharma Inc.
Via AccessWire
Tickers
CSE:LUV
Love Pharma Inc. Announces Closing of Financing
May 06, 2022
From Love Pharma Inc.
Via AccessWire
Tickers
CSE:LUV
Love Pharma Inc. Announces First Closing of Financing
April 05, 2022
From Love Pharma Inc.
Via AccessWire
Tickers
CSE:LUV
Love Pharma Updates Microdoz Proposed Acquisition with Global Leader in Psychedelic Research
March 03, 2022
From Love Pharma Inc.
Via AccessWire
Tickers
CSE:LUV
LOVE Pharma Announces Advanced Psilocybin Delivery System
October 20, 2021
From Love Pharma Inc.
Via AccessWire
Exposures
Product Safety
Tickers
CSE:LUV
Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange
October 12, 2021
From Love Pharma Inc.
Via AccessWire
Tickers
CSE:LUV
LOVE Pharma Names Joshua Maurice Chief Operating Officer
October 06, 2021
From Love Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:LUV
Love Pharma, Inc., Formerly Glenbriar Technologies, Inc., Announces Name Change, Consolidation, and Acquisition of Kick Pharmaceuticals, Inc
September 30, 2021
From Love Pharma Inc.
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
CSE:LUV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.